Del Mar has taken the first step in its piecemeal plan to lay out a new regime for regulating — and limiting — short-term rentals (STR’s), with an eye toward... It has stood guard over Fletcher Cove ...

Roche has staked a claim to use its oral selective oestrogen receptor degrader (SERD) giredestrant as a second-line therapy for breast cancer, regardless of a patient's ESR1 mutation status. Top-line ...